Detalhe da pesquisa
1.
Extracellular vesicles in anti-tumor immunity.
Semin Cancer Biol
; 86(Pt 1): 64-79, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34509614
2.
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma.
Oncologist
; 26(12): 1079-1084, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355463
3.
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention.
Int J Mol Sci
; 22(14)2021 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34299136
4.
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators.
Cell Commun Signal
; 18(1): 156, 2020 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967672
5.
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 20(9): 1252-1262, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331701
6.
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case.
J Immunother Cancer
; 12(1)2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177075
7.
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.
Cancer Epidemiol Biomarkers Prev
; 31(11): 2020-2029, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36112827
8.
3D tumor explant as a novel platform to investigate therapeutic pathways and predictive biomarkers in cancer patients.
Front Immunol
; 13: 1068091, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36591316
9.
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles.
J Invest Dermatol
; 142(11): 3030-3040.e5, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643181
10.
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer.
Cancer Discov
; 12(1): 90-107, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34789537
11.
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients.
Clin Transl Med
; 11(6): e434, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34185403
12.
Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.
Genes (Basel)
; 12(9)2021 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34573422
13.
microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.
Front Immunol
; 11: 1214, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32793185
14.
Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction.
Sci Rep
; 10(1): 3612, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107391
15.
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.
Hum Mutat
; 30(8): 1167-74, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19462467
16.
Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.
Virchows Arch
; 474(4): 407-420, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30374798
17.
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors.
J Immunother Cancer
; 7(1): 308, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31730502
18.
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.
J Clin Invest
; 128(12): 5505-5516, 2018 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30260323
19.
3D models for melanoma γδ T cell-based immunotherapy.
Clin Transl Med
; 12(6): e926, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696610
20.
Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer.
Vaccines (Basel)
; 4(4)2016 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27827921